Is Persistent Cough Affecting Your Quality of Life?
Exploring Chronic Cough in Participants with Idiopathic Pulmonary Fibrosis Clinical Trials
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterized by scarring (fibrosis) of lung tissue. One of its common and challenging symptoms is persistent coughing, which can interfere with everyday activities, sleep, social interactions, and overall quality of life.
Chronic cough affects a substantial number of individuals living with IPF. Despite available treatments that may help slow the progression of lung scarring, persistent cough remains an important symptom that requires further research.
Revive Research Institute is providing information about chronic cough in participants with idiopathic pulmonary fibrosis clinical trials in Michigan. This clinical research study is designed to evaluate the safety and efficacy of an investigational treatment, for managing chronic cough associated with IPF.
If you have been diagnosed with idiopathic pulmonary fibrosis and experience persistent coughing, participating in clinical research may provide an opportunity to contribute to the scientific understanding of IPF-related cough and the evaluation of potential treatment approaches.
You May Qualify for Chronic Cough Clinical Trials If You:
- Are ≥40 years of age.
- Have a confirmed diagnosis of idiopathic pulmonary fibrosis (IPF).
*Additional eligibility criteria apply.
*If you would like to learn more about chronic cough in participants with idiopathic pulmonary fibrosis clinical trials, complete the form to share your contact information. A member of the research team can contact you to discuss the study and determine whether you may qualify through an initial screening process. Participation is entirely voluntary.


